Oramed Pharmaceuticals Inc (ORMP)
2.33
0.00 (0.00%)
USD |
NASDAQ |
Nov 14, 16:00
2.33
0.00 (0.00%)
After-Hours: 20:00
Oramed Pharmaceuticals Net Income (Quarterly): 9.212M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 9.212M |
| March 31, 2024 | 1.536M |
| December 31, 2023 | 13.34M |
| September 30, 2023 | -3.222M |
| June 30, 2023 | -1.194M |
| March 31, 2023 | -3.395M |
| December 31, 2022 | -8.543M |
| September 30, 2022 | -7.06M |
| June 30, 2022 | -10.53M |
| March 31, 2022 | -10.42M |
| November 30, 2021 | -7.89M |
| August 31, 2021 | -6.853M |
| May 31, 2021 | -5.207M |
| February 28, 2021 | -4.608M |
| November 30, 2020 | -5.57M |
| August 31, 2020 | -2.996M |
| May 31, 2020 | -2.284M |
| February 29, 2020 | -3.688M |
| November 30, 2019 | -2.543M |
| August 31, 2019 | -2.28M |
| May 31, 2019 | -4.072M |
| February 28, 2019 | -3.701M |
| November 30, 2018 | -4.302M |
| August 31, 2018 | -2.926M |
| May 31, 2018 | -4.354M |
| Date | Value |
|---|---|
| February 28, 2018 | -2.916M |
| November 30, 2017 | -2.531M |
| August 31, 2017 | -2.696M |
| May 31, 2017 | -1.965M |
| February 28, 2017 | -3.183M |
| November 30, 2016 | -2.636M |
| August 31, 2016 | -4.76M |
| May 31, 2016 | -1.996M |
| February 29, 2016 | -1.818M |
| November 30, 2015 | -2.39M |
| August 31, 2015 | -2.116M |
| May 31, 2015 | -1.583M |
| February 28, 2015 | -1.637M |
| November 30, 2014 | -1.896M |
| August 31, 2014 | -1.629M |
| May 31, 2014 | -1.828M |
| February 28, 2014 | -1.115M |
| November 30, 2013 | -1.124M |
| August 31, 2013 | -0.791M |
| May 31, 2013 | -1.256M |
| February 28, 2013 | -1.226M |
| November 30, 2012 | -0.9588M |
| August 31, 2012 | -1.330M |
| May 31, 2012 | -0.5504M |
| February 29, 2012 | -0.9854M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-10.53M
Minimum
Jun 2022
13.34M
Maximum
Dec 2023
-3.259M
Average
-3.688M
Median
Feb 2020
Net Income (Quarterly) Benchmarks
| Skye Bioscience Inc | -7.903M |
| Scilex Holding Co | -37.58M |
| NovaBay Pharmaceuticals Inc | -1.585M |
| Palatin Technologies Inc | -8.250M |
| iBio Inc | -7.778M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 3.135M |
| EPS Diluted (Quarterly) | 0.22 |
| Enterprise Value | -58.86M |
| Earnings Yield | 21.89% |
| Normalized Earnings Yield | -21.89 |